Cell Signaling Technology

AKR1C2 Antibody

#13035 · $317

65
Citing papers
1.2k
Combined citations
Supplier page Find this product

Research areas

RNA modifications and cancer8Autophagy in Disease and Therapy5Aldose Reductase and Taurine4Adipose Tissue and Metabolism4Cancer, Lipids, and Metabolism4Fungal and yeast genetics research3Berberine and alkaloids research3Immune cells in cancer3

Papers citing this product

1
Ciliary membrane proteins traffic through the Golgi via a Rabep1/GGA1/Arl3-dependent mechanism
Nature Communications·2014·119 cit.·DOI
2
Carboxy Terminal Tail of Polycystin-1 Regulates Localization of TSC2 to Repress mTOR
PLoS ONE·2010·101 cit.·DOI
3
Long non‐coding <scp>RNA</scp> linc00261 suppresses gastric cancer progression <i>via</i> promoting Slug degradation
Journal of Cellular and Molecular Medicine·2016·100 cit.·DOI
4
Multicenter Validation of Cyclin D1, MCM7, TRIM29, and UBE2C as Prognostic Protein Markers in Non-Muscle–Invasive Bladder Cancer
American Journal Of Pathology·2012·77 cit.·DOI
5
Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells
British Journal of Cancer·2013·72 cit.·DOI
6
Chelerythrine induces apoptosis via ROS‐mediated endoplasmic reticulum stress and STAT3 pathways in human renal cell carcinoma
Journal of Cellular and Molecular Medicine·2019·53 cit.·DOI
7
Lipidomic Profiling Reveals Disruption of Lipid Metabolism in Valproic Acid-Induced Hepatotoxicity
Frontiers in Pharmacology·2019·51 cit.·DOI
8
Glycosylphosphatidylinositol-anchored Proteins Are Required for the Transport of Detergent-resistant Microdomain-associated Membrane Proteins Tat2p and Fur4p
Journal of Biological Chemistry·2005·46 cit.·DOI
9
Mitochondrial ROS Induced Lysosomal Dysfunction and Autophagy Impairment in an Animal Model of Congenital Hereditary Endothelial Dystrophy
Investigative Ophthalmology & Visual Science·2021·46 cit.·DOI
10
Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancer
Journal for ImmunoTherapy of Cancer·2022·37 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.